Rod Stables

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial

Adeel Shahzad, Ian Kemp, Christine Mars et al. · The Lancet · 2014 · 536 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions

David Hildick‐Smith, Adam J. de Belder, Nina Cooter et al. · Circulation · 2010 · 517 citations · Full text

Medicine, Cardiology, Surgery +17

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 295 citations · Full text

Medicine, Cardiology, Surgery +17

Long-Term Mortality Data From the Balloon Pump–Assisted Coronary Intervention Study (BCIS-1)

Divaka Perera, Rod Stables, Tim Clayton et al. · Circulation · 2012 · 235 citations · Full text

Medicine, Cardiology, Internal Medicine +17